Partnerships & Mergers

In 2021 alone, bacterial AMR directly caused 1.14 million deaths worldwide. Without immediate intervention, experts forecast that bacterial AMR will claim 39 million lives over the next 25 years

Amplifai Health’s acceptance into this programme validates the company’s approach to implementing AI technology in practical healthcare settings where it can make an immediate difference in patient care.

Through this acquisition, Mirum gains worldwide rights to brelovitug, a monoclonal antibody that has advanced to Phase III clinical development.

Altibbi plans to extend Zain Clinic to Kuwait, Bahrain, and the United Arab Emirates throughout 2026, building on its regional strategy to embed telehealth infrastructure into major digital platforms across the Gulf.

The advanced air mobility developer brings its cutting-edge autonomous aerial systems to move critical medical samples between SEHA Sheikh Khalifa Medical City (SKMC) and PureLab’s Abu Dhabi headquarters.

NMC will deploy Opus across its facilities to improve decision-making processes, streamline clinical and administrative workflows, and support better patient outcomes.

The merger has already cleared several regulatory hurdles, having secured approval from the Competition Commission of India (CCI) and received ‘No Objection’ letters from the Stock Exchanges.

BMS will pay up to USD850 million, structured as USD50 million in upfront and near-term payments combined with USD800 million in regulatory, development, and milestone-based payouts.

The newly developed syringe has been specifically engineered to work seamlessly with Ypsomed’s YpsoMate 5.5 autoinjector platform.

This move introduces advanced tools like the da Vinci robotic surgical system, promising to elevate medical care across the region.